Overall, available data indicates that HE4 could be a novel biomarker for early detection of ovarian cancer in high risk populations, and a multibiomarker panel with CA125 would be promising in detection, diagnosis, and prognosis. The gene discussed is WFDC2; the disease is ovarian cancer.